EverSource Wealth Advisors’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.6K Buy
3,039
+1,596
+111% +$9.63K ﹤0.01% 2662
2026
Q1
$8.89K Buy
1,443
+1,312
+1,002% +$10.9K ﹤0.01% 2977
2025
Q4
$1.36K Sell
131
-247
-65% -$2.48K ﹤0.01% 3623
2025
Q3
$3.4K Buy
378
+321
+563% +$2.82K ﹤0.01% 3313
2025
Q2
$741 Buy
57
+33
+138% +$496 ﹤0.01% 3804
2025
Q1
$606 Buy
24
+2
+9% +$59 ﹤0.01% 3398
2024
Q4
$756 Sell
22
-2,746
-99% -$124K ﹤0.01% 3061
2024
Q3
$137K Buy
2,768
+2,730
+7,184% +$140K 0.01% 691
2024
Q2
$1.74K Hold
38
﹤0.01% 2597
2024
Q1
$1.98K Hold
38
﹤0.01% 2387
2023
Q4
$1.53K Buy
+38
New +$1.11K ﹤0.01% 2261

Other funds holding RXST

EverSource Wealth Advisors's RXST Position: Q2 2026 in Review

EverSource Wealth Advisors increased its RxSight (RXST) stake by 111% in Q2 2026, buying an estimated $9.63K and bringing the position to 3,039 shares worth $14.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2662.

EverSource Wealth Advisors first reported a position in RXST in Q4 2023 and has held it in 11 quarters since. The position peaked at $137K in Q3 2024. 27 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • EverSource Wealth Advisors held 3,039 shares of RxSight worth $14.6K as of Q2 2026.
  • EverSource Wealth Advisors bought 1,596 RxSight shares in Q2 2026, an estimated $9.63K.
  • RxSight made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #2662 holding.
  • EverSource Wealth Advisors first reported a position in RxSight in Q4 2023 and has held it in 11 quarters since.
  • EverSource Wealth Advisors's RxSight position peaked at $137K in Q3 2024.
  • 27 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.